Amyloids are β-sheets-rich protein fibrils that cause neurodegenerative and other incurable human diseases affecting millions of people worldwide. However, a number of proteins is functional in the amyloid state in various organisms from bacteria to humans. Using an original proteomic approach, we identified a set of proteins forming amyloid-like aggregates in the brain of young healthy rats. One of them is the FXR1 protein, which is known to regulate memory and emotions. We showed that FXR1 clearly colocalizes in cortical neurons with amyloid-specific dyes Congo-Red, Thioflavines S and T. FXR1 extracted from brain by immunoprecipitation shows yellow-green birefringence after staining with Congo red. This protein forms in brain detergent-resistant amyloid oligomers and insoluble aggregates. RNA molecules that are colocalized with FXR1 in cortical neurons are insensitive to treatment with RNase A. All these data suggest that FXR1 functions in rat brain in amyloid form. The N-terminal amyloid-forming fragment of FXR1 is highly conserved across mammals. We assume that the FXR1 protein may be presented in amyloid form in brain of different species of mammals, including humans.
gates in the brains of six-month-old males of Rattus norvegicus, protein lysate was obtained from the total brain samples. The fraction of proteins forming SDS-resistant aggregates was isolated and purified using the PSIA-LC-MALDI proteomic approach 9 optimized for brain tissues. The proteins present in this fraction were solubilized, treated with trypsin, separated by HPLC and identified by mass spectrometry. The experiment was repeated independently with brain samples obtained from three animals. The proteins NSF, MBP, RIMS1, STXB1 and FXR1 were identified by mass-spectrometry in all three analyzed samples (Table 1 ; Supplementary Figs. S1-S5). All of these proteins, except MBP, contain potentially amyloidogenic regions predicted by the ArchСandy algorithm 20 ( Table 1) . Notably, there are some data suggesting that the myelin basic protein (MBP), that is a component of specialized membrane covering axons, may form amyloid structures in the brain 21 .
In this paper we focused on the analysis of the amyloid properties of the FXR1 protein that belongs to the Fragile X-Related (FXR) family of RNA-binding proteins, which also includes Fragile X Mental Retardation (FMRP) and Fragile X-Related 2 (FXR2) proteins 22 . The FXR2 and FMRP proteins, in contrast to FXR1, were not identified in SDS-resistant fractions. The FXR1 protein identified in our screen binds specific RNAs and is involved in regulation of long-term memory and emotion processing 14, 15 . Taking into consideration these neurospecific functions of FXR1, we decided to comprehensively analyze its amyloid properties in vivo and in vitro. FXR1 forms amyloid conformers in brain and colocalizes with mRNA molecules that are resistant to RNAse treatment. To check whether FXR1 aggregates in vivo, total protein lysate from the rat brain was separated into three fractions: (1) proteins less than 100 kDa; (2) soluble proteins larger than 100 kDa;
(3) insoluble aggregates. Using an FXR1-specific antibody we demonstrated that this protein is predominantly present in fractions containing oligomers and insoluble aggregates ( Fig. 1a,b ). Monomers of FXR1 were almost undetectable in the brain lysate ( Fig. 1a ). Two bands are detected in the oligomeric fraction and four bands are found in the fraction containing insoluble aggregates (Fig. 1a ). These results are in complete agreement with previously published data, according to which several isoforms of FXR1 protein exist in the mouse and rat brains due to alternative splicing of 3′ part of FXR1 mRNA [23] [24] [25] .
Known amyloids form SDS-resistant aggregates in vivo that may be detected by semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) 26, 27 . The total brain lysate was treated with 1% SDS and separated by agarose gel electrophoresis. A large portion of FXR1 formed detergent-insoluble aggregates ( Fig. 1c,d ). This result resembles the data of proteomic screening for amyloid-forming proteins according to that FXR1 forms SDS-resistant aggregates in vivo in all rat brain samples analyzed ( Supplementary Fig. S5 ).
To verify that FXR1 is present in amyloid form in brain, we compared the localization of FXR1 with the localization of amyloid-specific dyes Congo Red, Thioflavin S and Thioflavin T on cryosections of the brain cortex of young rats. The endogenous FXR1 protein was detected in the perinuclear cytoplasm of cortical neurons (Fig. 2a ). The amyloid-specific dye Congo red was detected by confocal microscopy as described previously 28 . The location of FXR1 precisely coincided with the signals of Congo red. Colocalization of FXR1 and Congo red was estimated using Pearson's coefficient for 100 random cells, shown as mean ± SEM ( Supplementary Fig. S6 ).
Protein Function

Amyloidogenic regions of the protein as predicted by ArchCandy
NSF
Catalyzes the fusion of transport vesicles within the Golgi cisternae and is required for transport from the endoplasmic reticulum to the Golgi stack 41 Table 1 . The proteins forming SDS-resistant aggregates in rat brain.
Pearson correlation coefficient was 0,72 ± 0,05. However, we did not detect the yellow-green birefringence seen under crossed polarized light. The yellow-green birefringence produced by Congo red stained deposits is a gold standard for amyloids detection. This approach is applicable to detect extracellular deposits or large condensed intracellular amyloid granules. We suggested that the sensitivity of this method is not sufficient for detection of the FXR1 conformers in the cytoplasm of neurons. To test this hypothesis, FXR1 was extracted from brain by immunoprecipitation, concentrated by centrifugation and immediately stained with Congo Red. The results presented in the Fig. 2b shows that FXR1 immunoprecipitated from brain binds Congo red and demonstrates yellow-green birefringence under crossed polarized light. Fibrils of FXR1 extracted from rat brain using immunoprecipitation were visualized by TEM ( Fig. 2c ). FXR1 also colocalizes in cortical neurons with amyloid-specific dyes Thioflavin S (Figs. 3a and S6) and Thioflavin T ( Supplementary Fig. S7 ). Taking into consideration that FXR1 forms SDS-resistant aggregates, colocalizes with all three amyloid specific dyes and shows yellow-green birefringence under crossed polarized light, we can conclude that this protein is present in rat brain in amyloid form under native conditions. FXR1 is known to bind different RNA molecules and affects their stability and translation efficiency 17 . To analyze the binding of FXR1 with mRNA, the brain cryosections were hybridized with biotinylated poly-dT, subsequently visualized by avidin-Alexa Fluor 488 and immunostained with anti-FXR1 antibody. As expected, we demonstrated that FXR1 colocalizes with a portion of mRNA in the cytoplasm of cortical neurons, whereas an essential part of mRNA is not associated with this protein (Fig. 3b ). To check stability of mRNA molecules colocalized with amyloid conformers of FXR1, cryosections of the brain cortex were treated with RNase A in extremely high concentration (500 μg/ml). Then cryosections were hybridized with poly-dT and immunostained with anti FXR1-antibody. Molecules of mRNA that are colocalized with FXR1 were clearly detected after treatment with RNase A, whereas other mRNA molecules had completely degraded ( Fig. 3c ). Figure 1 . FXR1 forms SDS-resistant oligomers and aggregates in rat brain. (a) FXR1 is present in brain in fraction of oligomers and insoluble aggregates. Total protein lysate was divided into fractions of monomers less than 100 kDa, oligomers larger than 100 kDa, and insoluble aggregates. The fractions were subjected to SDD-PAGE and analyzed by immunoblotting with anti-FXR1 antibodies. (b) Relative intensity of bands corresponding to FXR1 monomers, oligomers and insoluble aggregates is represented as mean ± SEM for three independent brain samples. (c) A large portion of FXR1 in rat brain forms SDS-resistant aggregates. Total rat brain lysate was treated with1% SDS at RT, subjected to SDD-AGE, and analyzed by immunoblotting with anti-FXR1 antibodies. (d) Relative intensity of bands corresponding to FXR1 monomers and SDS-resistant aggregates is represented as mean ± SEM for three independent brain samples. www.nature.com/scientificreports www.nature.com/scientificreports/ In order to check whether the FXR1(1-379)-YFP chimeric protein, like other amyloids, forms solid, immobile aggregates, the FRAP analysis was performed. The FXR1(1-379)-YFP protein located inside the fluorescent aggregates, unlike FXR1(380-568)-YFP, is virtually immobile (Fig. 5 ). This is characteristic of dense, compact structures, in particular, amyloids. A slight restoration of fluorescence intensity is usually explained by the dynamics of small oligomers, which have some mobility.
The amyloid properties of the N-terminal fragment of FXR1 were also analyzed in vitro. The 6xHis-FXR1(1-379) recombinant protein immediately aggregated when placed into Tris buffer at 37 °C, however microscopically discernible fibrils were detected only after 48 hours of incubation with slow rotation (Fig. 6a ). These fibrils bound Congo Red ( Fig. 6b ) and manifested yellow-green birefringence when assayed by polarization microscopy (Fig. 6c ).
To verify amyloid properties of the N-terminal fragment of FXR1, we also used the bacterial curli-dependent amyloid generator (C-DAG) system for production of extracellular amyloid fibrils 29, 30 . This system relies on the ability of E. coli cells to generate surface associated amyloid fibrils (curli) composed of CsgA protein. This protein contains an N-terminal signal sequence (CsgA SS ) that directs it to the cell surface and a C-terminal sequence that allows formation of extracellular fibrils 31, 32 . Joining the signal sequence (CsgA SS ) to heterologous amyloidogenic protein fragments directs their export to the cell surface where they can form fibrils. Since the C-DAG is applicable for the study of relatively short protein fragments 30 , we analyzed the amyloidogenic properties of the N-terminal fragment of FXR1 spanning the first 337 amino acids. The E. coli VS39 strain was transformed with the pVS-FXR1(1-337) plasmid providing expression of CsgA SS fused to the FXR1(1-337) fragment. The VS39 cells expressing CsgA SS -Sup35NM and CsgA SS -Sup35M proteins were used as positive and negative controls, respectively. We showed that expression of CsgA SS -FXR1(1-337) resulted in red colonies of transformants, although the red coloration was not as intense as in transformants expressing CsgA SS -Sup35NM (Fig. 7a ). The transformants expressing CsgA SS -Sup35M protein were pale on the medium containing Congo Red (Fig. 7a ). CsgA SS -FXR1(1-337) and CsgA SS -Sup35NM proteins, but not CsgA SS -Sup35M, bound Congo Red and Supplementary  Fig. S8 ). Both, E and D, belong to the class of the polar negatively charged amino acids, and this replacement is unlikely to change the amyloidogenic properties of the FXR1 protein. The N-terminal sequences of human, cat and macaque FXR1 proteins are identical. The FXR1N sequence of Bos taurus differs by two amino acids from the rat sequence ( Figs. 8 and S8 ). The N-terminal regions of FXR1 proteins of non-mammalian vertebrates differ from the rat FXR1N more significantly, but all of them contain two identically arranged potentially amyloidogenic regions (Fig. 8 ). The C-terminal parts of FXR1 proteins of some species lack short regions before the RGG RNA-binding motive. No potentially amyloidogenic regions were revealed in FXR1C in all species analyzed. Thus, the N-terminal amyloid-forming region of FXR1 is highly conserved in the mammalian lineage and contains identically arranged amyloidogenic sequences in vertebrate species.
We tested the ability of the FXR1 protein to form amyloid aggregates in a human neuroblastoma cell culture. IMR32 cells grown on coverslips were fixed, and immunostaining was performed to localize FXR1. At the next step, the cells were stained with Thioflavin S. FXR1 forms both diffuse and granular structures around the nucleus of neuroblastoma cells (Fig. 9a,b ). Most important, FXR1 colocalizes with the signals of Thioflavin S (Fig. 9c) . These data support our hypothesis that the FXR1 protein is presented in amyloid form in neuronal cells.
Discussion
Proteomic screening, based on the universal biochemical properties of amyloids, provides us with new opportunities for the study of the prevalence and role of amyloids in nature. Using an original proteomic approach, we identified a set of proteins forming amyloid-like aggregates in the rat brain. The data obtained by PSIA-LC-MALDI opens up broad prospects for further identification of functional amyloids in mammalian brain. We focused on the analysis of amyloid properties of the FXR1 protein, but at the same time we identified several other promising candidates for the role of functional amyloids. The NSF, MBP, RIMS1 and STXB1 proteins were identified by mass-spectrometry in the SDS-resistant fraction of all analyzed brain samples (Table 1 ; Supplementary Figs. S1-S5). All of them, except MBP, contain potentially amyloidogenic regions predicted by ArchCandy algorithm. The analysis of their amyloid properties will be the subject of further research. Notably, there are some data suggesting that the myelin basic protein (MBP), that is a component of specialized membrane covering axons, may normally form amyloid structures in the brain 21 . The CPEB3 protein was not identified in the SDS-resistant fraction in our proteomic screen. This is not surprising, since it was shown in the mouse model that CPEB3 aggregates only in the brains of specifically stimulated animals 8 .
The FRX1 protein identified by proteomic screening forms oligomers and large insoluble aggregates in rat brain. The monomers of FXR1 are almost undetectable (Fig. 1a ). We showed that this protein, like other well-known amyloids, forms SDS-resistant conformers (Fig. 1c) . Moreover, FXR1 clearly colocalizes with amyloid-specific dyes Congo Red, Thioflavin S and Thioflavin T on cryosections of rat cerebral cortex (Figs. 2a, 3a and S7). FXR1 extracted from brain by immunoprecipitation shows yellow-green birefringence after staining with Congo red (Fig. 2b) . Taking together, all these data demonstrate that FXR1 presents in brain of healthy rats in the amyloid form. Functional role of amyloid conformers of FXR1 in mammalian brain remains to be elucidated. Previously it was shown that the FXR1 protein contains KH and RGG RNA-binding motives and differently regulates RNA stability and translation 17 . Changes in the expression level of this protein in brain cortex affect long-term memory and emotional state 14, 15 . We demonstrated that amyloid conformers of FXR1 in neurons are colocalized with mRNA molecules resistant to RNAse treatment (Fig. 3c ). Based on these data, we assume that the RNP particles containing FXR1 protect RNA from degradation. At the same time, cytological data do not allow to draw a final conclusion about protective function of FXR1 amyloid. We cannot exclude the possibility that other proteins interacting with FXR1 or with FXR1-bound mRNAs affect the stability of RNA as a part of the FXR1-containing RNP particles. It was previously shown that FXR1 may be involved in the stress granule formation in cell culture, but only under adverse conditions 34, 35 . However, we analyzed brain cryosections of young healthy animals that were not exposed to stress. Taking into account the clear colocalization of FXR1 with a stable mRNA fraction in cortical neurons, the hypothesis that amyloid conformers of FXR1 perform protective functions seems to be the most justified. The protection of RNA mediated by amyloid-based RNP particles can be an important component of the regulation of gene expression in such long-living cells as neurons.
The N-terminal part of FXR1 contains algorithmically predicted potentially amyloidogenic regions (Table 1) . We confirmed these amyloid properties of N-terminal fragment of FXR1 using a yeast-based system, in vitro experiments and the bacterial-based C-DAG system (Figs. 4-7) . Moreover, N-terminal fragment of FXR1 is highly conserved across mammals and contains identically arranged potentially amyloidogenic sequences in evolutionary distant vertebrates ( Figs. 8 and S8) . These data suggest that amyloid properties of FXR1 are evolutionary conserved, especially in the mammalian lineage including humans. Our data obtained in human neuroblastoma cells ( Fig. 9 ) confirm this hypothesis.
Taken together, we provide comprehensive evidence that the RNA-binding protein FXR1 is present in the amyloid form in the rat brain and its N-terminal amyloidogenic fragment is evolutionarily conserved. Our data open up prospects for studying the functional role of amyloids in the mammalian brain. 
Proteomic screening and identification of proteins forming amyloid-like aggregates. Proteomic
screening and identification of proteins forming amyloid-like aggregates in brain of Rattus norvegicus were performed using PSIA-LC-MALDI approach described recently 9 , with modifications. Brain homogenates were solubilized in Tris-buffered saline (TBS) (30 mM Tris-HCl, pH 7.4, 150 mM NaCl), supplemented with www.nature.com/scientificreports www.nature.com/scientificreports/ 10 mM PMSF and Complete Protease Inhibitor (Roche). The obtained lysates were fractionated by ultracentrifugation (151000 g, 2 h, 4 °C). Pellets containing protein aggregates were resuspended in TBS with 200 µg/ ml RNase A (Thermo Fisher, USA), incubated for 15 min and treated with 1% SDS for 8 hours at 18 °C. Then, detergent-resistant protein complexes were separated by ultracentrifugation at 151000 g (8 h, 18 °C) through 25% sucrose-TBS cushion with 0.1% SDS. Pellets were suspended in water, sedimentated again at 151000 g (2 h, 4 °C) and denatured. After trypsinolysis the peptide mixtures were loaded (1 μl) onto an Acclaim PepMap 300 HPLC reverse-phase column (150 mm, 75 μm, particle size 5 μm; Thermo Scientific, USA) and separated in an acetonitrile gradient (2-90%) during 45 min using an UltiMate 3000 UHPLC RSLC nano high-performance nanoflow liquid chromatograph (Dionex, USA). Peptide fractions were collected every 10 s and loaded onto a 384-sample MTP AnchorChip 800/384 microtiter plate (Bruker Daltonics) using a Proteineer fc II spotter (Bruker Daltonics).
Peptides were identified using the Ultraflextreme MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, DE). MS-spectra for each peptide fraction were determined and analyzed using WARP-LC software. MS/ MS-analysis was performed for these peptides in fractions (spots) with maximal concentration (peak intensity) of these peptides. Match between the experimental spectra and corresponding proteins was analyzed using Mascot www.nature.com/scientificreports www.nature.com/scientificreports/ version 2.4.2 software (Matrix Science; http://www.matrixscience.com) in the UniProt database (http://www. uniprot.org/) restricted to Rattus norvegicus. α-cyano-4-hydroxycinnamic acid was used as a matrix. During analysis, preset parameters of "Mass tolerance" were used (precursor mass tolerance 100 ppm, fragment mass tolerance 0.9 Da). As a standard sample, Peptide Calibration Standard II 8222570 (Bruker Daltonics) was applied. Carboxymethylation of cysteine, partial oxidation of methionine, and one skipped trypsinolysis site were considered as permissible modifications. The BioTools software (Bruker, Bremen, Germany) was used for manual validation of protein identification. Rat brain slices and homogenization. For immunohistochemistry and fluorescent in situ hybridization rat brains were extracted, washed with PBS and fixed in 4% PFA for 3 hours. After fixation brains were embedded in FSC22 compound (Leica), frozen in liquid nitrogen and stored at −70 °C. Brains were sectioned to 20 µm thick slices on a freezing microtome CM1850UV (Leica). For PSIA-LC-MALDI analysis brains after extraction were immediately frozen in liquid nitrogen and homogenized using a cryogenic laboratory mill Freezer/Mill 6870 (SPEX SamplePrep).
Immunohistochemistry, FISH, FRAP and immunoprecipitation. Immunohistochemistry and
histological staining were performed on rat brain cryosections and IMR32 fixed cells. The primary Anti-FXR1 antibody ab129089 (1:200, Abcam, Cambridge, MA) and secondary antibody Goat anti-Rabbit IgG (H + L) conjugated with Alexa Fluor 546 or with Alexa Fluor 488 (1:500, ThermoFisher Scientific, USA) were used. The slides were also subjected to DAPI nuclear staining. Histological staining for amyloids was done using 0.1 mg/ ml Congo red water solution. Staining for amyloids also was done using 1% Thioflavin S and Thioflavin T solutions for the rat brain cryosections and 0.05% Thioflavin S solution for the IMR32 cells. The polyA mRNA on rat brain cryosections was detected with biotinylated oligo(dT)20 (Beagle, Russia) followed by avidin conjugated with AlexaFluor488 (1:200, ThermoFisher Scientific, USA). Enzymatic treatment was performed with RNaseA (500 µg/ml, ThermoFisher Scientific, USA) for one hour at 37 °C. The analysis of colocalization of the fluorescent labeled antibodies for the FXR1 protein with the amyloid specific dyes or with polyA mRNA was performed using a TCS SP5 confocal microscope (Leica Microsystems, Germany) and "Leica Application Suite X 3.3.0.16799" software. The colocalization of FXR1 with Congo red and Thioflavin S was analyzed by Pearson correlation analysis using the coloc2 plugin of FIJI software (http://fiji.sc/Fiji).
FRAP experiments using living S. cerevisiae cells expressing YFP-tagged proteins were acquired on a Leica TCS SP5 confocal microscope and were performed as described earlier 36 . A bleach region was bleached by ten iterations of 100% laser power. Five initial pre-bleach images and 25 subsequent post-bleach images were acquired with an interval of 30 seconds, and normalized fluorescence recovery was analyzed using FIJI software (http://fiji.sc/Fiji).
For immunoprecipitation of FXR1 from rat brain the anti-FXR1 antibodies ab129089 (Abcam, Cambridge, MA) were bound to protein A coated SileksMagX-Protein A magnetic beads (Sileks, Moscow, Russia) and incubated with R. norvegicus brain lysate with addition of Complete Protease Inhibitor (Roche) (+4 °C, overnight). Protein elution was performed in glycine buffer according to manufacturer's protocol (Sileks, Moscow, Russia). Then the sample was concentrated by centrifugation at 130 000 g for 2 h, stained with Congo Red dye and analysed by brightfield, polarization and TEM microscopy.
Cloning of the FXR1 gene fragments. Total rat RNA was extracted from brain homogenates using TRIzol reagent (Invitrogen) according to the manufacturer protocol. cDNA synthesis was performed with SuperScript III Reverse Transcriptase (Invitrogen). cDNA was further used for FXR1 fragments synthesis. The fragment of FXR1 gene coding for 1-379 aa for expression in E. coli was amplified with fxr1EcoRIforward and fxr1(379) BamHIreverse primers and inserted into pET302 vector to obtain the pET302-FXR1(1-379) plasmid. The fragment of FXR1 gene coding for 1-379 aa for expression in S. cerevisiae was amplified with fxr1HindIIIforward and fxr1(YFP)BamHIreverse primers. The fxr1(380)HindIIIforward and fxr1(568)BamHIreverse primers were used for amplification of the fragment of FXR1 gene coding for 380-568 aa. Both fragments were inserted in pCUP-YFP vector to obtain pCUP-FXR1(1-379)-YFP and pCUP-FXR1(380-568)-YFP plasmids. The fragment of the FXR1 gene coding for 1-337 aa for expression in C-DAG system was amplified with fxr1NotIforward and fxr1XbaIreverse primers and this fragment was inserted into pVS72 vector to obtain the pVS-FXR1(1-337) plasmid. All primers are listed in SupplementaryTable S1. In vitro fibril formation assay. The experiment was performed as described previously 37 . In brief, purified FXR1(1-379) protein solution diluted to 5 μM in a buffer containing 20 mM Tris (pH 8.0), 1 mM βME was incubated at 37 °C under agitation for 48 hr with slow rotation. Fibril formation was verified by TEM and Congo Red staining.
Recombinant protein expression and purification.
Protein analysis. Preparation of protein lysates was performed as described previously 38 with addition of RNase A (Thermo Fisher, USA) to the lysis buffer to final concentration 200 µg/ml. Rat brain lysates were fractionated for 25 min at 9800 g, +4 °С, and the insoluble fraction was collected. The supernatant was loaded on the Amicon Ultra 100 K filter (Merck, Millipore) and further divided into two fractions: less than 100 kDa and more than 100 kDa. The FXR1 protein was detected with the primary Anti-FXR1 antibody ab129089 (Abcam) and secondary Goat Anti-Rabbit IgG H&L (ab205718) (HRP) (Abcam). Chemiluminescent detection was performed using the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare, USA).
Fractionation of yeast cell lysates was performed according to 39 . The cells were harvested, washed in water, and homogenized by glass beads in a buffer A: 25 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM dithiothreitol. To prevent proteolytic degradation, 10 mM EDTA, 2 mM PMSF, and Complete ™ protease inhibitor mixture (Roche Applied Science) were added. Cell lysate was centrifuged for 25 min at 9800 g, +4 °С, then supernatant was transferred to a new tube and debris was suspended in equal buffer volume. Semi-denaturing detergent agarose gel electrophoresis (SDD-AGE) 11, 23 was performed using 1% agarose gel. Before loading onto a gel, protein extracts were treated for 10 min with 1% SDS at room temperature. Proteins fused with YFP were detected with polyclonal chicken primary antibodies against GFP (ab13970, Abcam, Great Britain) and secondary Goat Anti-Chicken IgY H&L (HRP) (ab6877, Abcam). Chemiluminescent detection was performed using the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare, USA).
Yeast strains and growth conditions. The S. cerevisiae strain BY4742 40 [MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0] was used for analysis of the FXR1 fragments aggregation. Standard yeast genetic techniques, media, and cultivation conditions were used. 150 μM copper sulfate (CuSO 4 ) was added to synthetic medium to induce the expression of genes under the P CUP1 promoter.
Analysis of amyloid fibril formation in the bacteria-based system C-DAG. The analysis of amyloid fibril formation of FXR1(1-337aa) fragment in the bacteria-based C-DAG system was performed as described earlier 29, 30 . E. coli strain VS39 was transformed with the plasmid pVS-FXR1(1-337) coding for FXR1(1-337) protein fused to CsgA signal sequence. VS39 transformants with pVS72 and pVS105 encoding the CsgA SS -Sup35NM and CsgA SS -Sup35M proteins were used as positive and negative controls of amyloid generation, respectively.
Data availability
All data generated and analyzed during this study are available from the corresponding author on reasonable request.
